Company
Headquarters: Mexico City, DF, Mexico
Employees: 2,221
MX$13.89 Billion
MXN as of Jan. 1, 2024
US$818.3 Million
Company | Market Cap (USD) |
---|---|
Zoetis Inc. | $89.09 B |
MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
Takeda Pharmaceutical Company Limited | $47.71 B |
Haleon plc | $38.90 B |
PPD, Inc. | $16.58 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Genomma Lab Internacional, S.A.B. de C.V. together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico, the United States, and Latin America. It offers skin care products under the Cicatricure, Asepxia, and Teatrical brands; hair care products under the Vanart, Medicasp, Tío Nacho, and Sistema GB brands; razor products under the Groomen brand; hydrating beverage under the Suerox brand; and nutritional products for child under the Novamil brand. The company also provides pain relief products under the Alliviax brand; cough and cold medicines under the Tukol and Next brands; and antibacterial products under the Bufferin, XL-3, and Next-AB brands. In addition, it offers HIV diagnosis product under the OraQuick brand. Genomma Lab Internacional, S.A.B. de C.V. was founded in 1996 and is based in Mexico City, Mexico.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Genomma Lab Internacional, S.A.B. de C.V. has the following listings and related stock indices.
Stock: BMV: LABB wb_incandescent
Stock: FSX: GEKA wb_incandescent